These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23007440)

  • 21. Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review.
    Zhao P; Zhang L; Grillo JA; Liu Q; Bullock JM; Moon YJ; Song P; Brar SS; Madabushi R; Wu TC; Booth BP; Rahman NA; Reynolds KS; Gil Berglund E; Lesko LJ; Huang SM
    Clin Pharmacol Ther; 2011 Feb; 89(2):259-67. PubMed ID: 21191381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiologically based pharmacokinetic modeling of nanoparticles.
    Li M; Al-Jamal KT; Kostarelos K; Reineke J
    ACS Nano; 2010 Nov; 4(11):6303-17. PubMed ID: 20945925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moving from external exposure concentration to internal dose: duration extrapolation based on physiologically based pharmacokinetic derived estimates of internal dose.
    Simmons JE; Evans MV; Boyes WK
    J Toxicol Environ Health A; 2005 Jun 11-25; 68(11-12):927-50. PubMed ID: 16020185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiologically-based pharmacokinetic (PBPK) models in toxicity testing and risk assessment.
    Lipscomb JC; Haddad S; Poet T; Krishnan K
    Adv Exp Med Biol; 2012; 745():76-95. PubMed ID: 22437814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: the first steps.
    Loizou G; Spendiff M; Barton HA; Bessems J; Bois FY; d'Yvoire MB; Buist H; Clewell HJ; Meek B; Gundert-Remy U; Goerlitz G; Schmitt W
    Regul Toxicol Pharmacol; 2008 Apr; 50(3):400-11. PubMed ID: 18331772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a physiologically based pharmacokinetic model for bisphenol A in pregnant mice.
    Kawamoto Y; Matsuyama W; Wada M; Hishikawa J; Chan MP; Nakayama A; Morisawa S
    Toxicol Appl Pharmacol; 2007 Oct; 224(2):182-91. PubMed ID: 17698157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of physiologically based pharmacokinetic modeling in regulatory review.
    Huang SM; Rowland M
    Clin Pharmacol Ther; 2012 Mar; 91(3):542-9. PubMed ID: 22318616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural identifiability of PBPK models: practical consequences for modeling strategies and study designs.
    Slob W; Janssen PH; van den Hof JM
    Crit Rev Toxicol; 1997 May; 27(3):261-72. PubMed ID: 9189655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans.
    Tardif R; Charest-Tardif G; Brodeur J; Krishnan K
    Toxicol Appl Pharmacol; 1997 May; 144(1):120-34. PubMed ID: 9169076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steady-state solutions to PBPK models and their applications to risk assessment I: Route-to-route extrapolation of volatile chemicals.
    Chiu WA; White P
    Risk Anal; 2006 Jun; 26(3):769-80. PubMed ID: 16834633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of PK- and PBPK-based modeling tools for derivation of biomonitoring guidance values.
    Bartels M; Rick D; Lowe E; Loizou G; Price P; Spendiff M; Arnold S; Cocker J; Ball N
    Comput Methods Programs Biomed; 2012 Nov; 108(2):773-88. PubMed ID: 22704290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of physiologically based pharmacokinetic models for use in risk assessment.
    Chiu WA; Barton HA; DeWoskin RS; Schlosser P; Thompson CM; Sonawane B; Lipscomb JC; Krishnan K
    J Appl Toxicol; 2007; 27(3):218-37. PubMed ID: 17299829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mathematical modeling and simulation in animal health - Part II: principles, methods, applications, and value of physiologically based pharmacokinetic modeling in veterinary medicine and food safety assessment.
    Lin Z; Gehring R; Mochel JP; Lavé T; Riviere JE
    J Vet Pharmacol Ther; 2016 Oct; 39(5):421-38. PubMed ID: 27086878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly.
    Thompson CM; Johns DO; Sonawane B; Barton HA; Hattis D; Tardif R; Krishnan K
    J Toxicol Environ Health B Crit Rev; 2009 Jan; 12(1):1-24. PubMed ID: 19117207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The successes and failures of physiologically based pharmacokinetic modeling: there is room for improvement.
    Poggesi I; Snoeys J; Van Peer A
    Expert Opin Drug Metab Toxicol; 2014 May; 10(5):631-5. PubMed ID: 24517185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applications of computational toxicology methods at the Agency for Toxic Substances and Disease Registry.
    el-Masri HA; Mumtaz MM; Choudhary G; Cibulas W; De Rosa CT
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):63-9. PubMed ID: 12018017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interspecies extrapolation.
    Kenyon EM
    Methods Mol Biol; 2012; 929():501-20. PubMed ID: 23007441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiological modeling of age-specific changes in the pharmacokinetics of organic chemicals in children.
    Price K; Haddad S; Krishnan K
    J Toxicol Environ Health A; 2003 Mar; 66(5):417-33. PubMed ID: 12712630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using population physiologically based pharmacokinetic modeling to determine optimal sampling times and to interpret biological exposure markers: The example of occupational exposure to styrene.
    Verner MA; McDougall R; Johanson G
    Toxicol Lett; 2012 Sep; 213(2):299-304. PubMed ID: 22677344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QSARs for PBPK modelling of environmental contaminants.
    Peyret T; Krishnan K
    SAR QSAR Environ Res; 2011 Mar; 22(1-2):129-69. PubMed ID: 21391145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.